Lily Allen Shuts Down Drug Rumors, Gives Mental Health Update: ‘I'm Really Not in a Good Place'
Lily Allen just gave fans another update on her mental health, shutting down rumors that she's been using drugs. On the ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment
Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
CMS confirms to CNBC Medicare plans can now cover Zepbound for sleep apnea
The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug ...
3 Stocks to Buy for 2025 That Are Practically Money Machines
Eli Lilly should become a much bigger money machine with multiple growth drivers in its product lineup and a promising ...
Lily Allen says she’s ‘spiraling’ and ‘not in a good place’ amid David Harbour split rumors
Lily Allen is struggling. The British singer, 39, broke down on Thursday’s episode of her “Miss Me?” podcast and opened up to ...
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Lily Allen admits she’s ‘spiraling’ and ‘not in a good place’ as David Harbour divorce rumors ramp up
When things are not going so well and life is tough, as it is for many people for all manner of reasons, having to hold things together is really hard.” ...